Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_assertion type Assertion NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_head.
- NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_assertion wasGeneratedBy ECO_0000203 NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_provenance.
- NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_assertion wasDerivedFrom befree-20150227 NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_provenance.
- NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_assertion SIO_000772 24468836 NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_provenance.
- NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_assertion evidence source_evidence_literature NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_provenance.
- NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_provenance.